Triple
T22662114
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH E2D |
E559691
|
entity |
| Predicate | relatedTo |
P37
|
FINISHED |
| Object | ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting | Statement: [ICH E2D, relatedTo, ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting Context triple: [ICH E2D, relatedTo, ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting]
-
A.
ICH E2A Clinical Safety Data Management
chosen
ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
-
B.
Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs (ICH E2C) is an international guideline that standardizes the format, content, and timing of periodic safety reports submitted by marketing authorization holders to monitor and communicate the ongoing safety profile of approved medicines.
-
C.
International Council for Harmonisation guideline E2C
International Council for Harmonisation guideline E2C is a regulatory framework that provides standardized requirements for the ongoing safety evaluation and periodic benefit-risk assessment of marketed medicinal products.
-
D.
ICH E9 Statistical Principles for Clinical Trials
ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.
-
E.
Clinical Trials Information System
The Clinical Trials Information System is the EU’s centralized online portal and database for the submission, assessment, authorization, and public transparency of clinical trials conducted in the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454a158c819093b8e35f5045efb6 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1765fe7d081908087778c54c1e612 |
completed | April 29, 2026, 3:09 a.m. |
Created at: April 17, 2026, 3:08 p.m.